A common ingredient found in most oral over-the-counter cold medicines should be removed from the market because it doesn’t ...
Oral phenylephrine, a common nasal-congestion ingredient in over-the-counter drugs, shouldn't be used in monograph drug products, the Food and Drug Administration is proposing. The agency said a ...
Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...
In a long-sought move, the Food and Drug Administration on Thursday formally began the process of abandoning oral doses of a ...
Cold and flu season is upon us and Americans will be flocking to pharmacy shelves to pick up some medicine to alleviate their ...
The FDA announced a proposal to remove oral phenylephrine – a common ingredient in many popular over-the-counter ...
Sinus infections (also known as sinusitis) strike more than 30 million Americans each year. And if you’re one of them, you’re ...
The FDA would provide manufacturers with appropriate time to either reformulate drugs containing oral phenylephrine or remove ...
The agency said its experts poured over decades of data on whether or not phenylephrine could ease nasal congestion. They ...
The FDA proposed discontinuing the use of phenylephrine, an ingredient in common medications like Sudafed, because it 'is not ...